Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase delta (Pol δ) is a multi-subunit enzyme complex found in eukaryotic cells, playing a central role in chromosomal DNA replication, repair, and recombination. It is one of the primary replicative polymerases responsible for synthesizing both the leading and lagging strands during DNA replication. Human Pol δ consists of four subunits: p125 (catalytic; encoded by POLD1), p50 (POLD2), p68 (POLD3), and p12 (POLD4). The enzyme’s processivity is greatly enhanced by its interaction with proliferating cell nuclear antigen (PCNA). Beyond replication, Pol δ participates in various repair pathways. Improper regulation or mutation within any component/subunit can disrupt normal cell cycle progression or damage response pathways, and defects have been linked with tumorigenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Polymerase Delta (None).